Jun 19
|
Battery Simulation Software Market worth $4.19 billion by 2030- Exclusive Report by MarketsandMarkets™
|
Jun 17
|
Avio Digitally Transforms the Development of Innovative Space Technologies with Dassault Systèmes’ 3DEXPERIENCE Platform
|
May 23
|
Pharma tech CFO says finance is at the center of AI strategy
|
Apr 18
|
Stocks to watch next week: Tesla, Alphabet, Intel, Boeing and Unilever
|
Apr 17
|
Is Dassault Systemes (DASTY) Stock Outpacing Its Computer and Technology Peers This Year?
|
Oct 7
|
Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of September 30, 2024
|
Oct 7
|
Dassault Systèmes Employee Sets GUINNESS WORLD RECORDS™ Title in Paracycling in New Milestone for Inclusive Mobility
|
Sep 5
|
Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of August 31, 2024
|
Sep 3
|
Medidata and Aixial Group partner to streamline clinical trial execution
|
Sep 3
|
Aixial Group Migrates Specific Clinical Data Portfolio Onto Medidata Platform to Create a Single Source of Truth and Accelerate Database Lock
|
Jul 26
|
Eisai adopts Medidata’s AI-driven platform for clinical trials
|
Jul 26
|
Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience
|
Jul 25
|
Dassault Systèmes: Availability of the 2024 Half-year Financial Report
|
Jul 25
|
ASICS and Dassault Systèmes Demonstrate On-Demand, Personalized Footwear
|
Jul 25
|
Dassault Systèmes: Second Quarter 2024 Results in Line With Preliminary Announcement - Non-IFRS Diluted EPS up 10% in the First Half
|
Jul 25
|
Dassault Systèmes: Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience
|
Jun 20
|
Dassault Systèmes’ 3DEXPERIENCE Platform on the Cloud Selected by Mahindra & Mahindra as It Accelerates Its Digital Transformation
|
Jun 19
|
Medidata introduces new AI-powered platform for clinical trials
|
Jun 18
|
Medidata Launches Clinical Data Studio, Leveraging AI to Modernize the Data Experience in Clinical Trials
|
Apr 9
|
Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of March 31, 2024
|